Neuropediatrics 2007; 38(2): 100-104
DOI: 10.1055/s-2007-985139
Short Communication

Georg Thieme Verlag KG Stuttgart · New York

Progressive Unilateral Hemispheric Atrophy in an Infant with Neurofibromatosis

P. Wintermark 1 , K. Meagher-Villemure 2 , J.-G. Villemure 3 , M. Maeder-Ingvar 4 , P. Maeder 5 , S. Ghariani 1 , E. Roulet-Perez 1
  • 1Unit of Pediatric Neurology and Rehabilitation, Medico-Surgical Department of Pediatrics, University Hospital (CHUV) and Lausanne Medical School, Lausanne, Switzerland
  • 2Unit of Pedopathology, Institute of Pathology, University Hospital (CHUV) and Lausanne Medical School, Lausanne, Switzerland
  • 3Department of Neurosurgery, University Hospital (CHUV) and Lausanne Medical School, Lausanne, Switzerland
  • 4Department of Neurology, University Hospital (CHUV) and Lausanne Medical School, Lausanne, Switzerland
  • 5Unit of Neuroradiology, Department of Radiology, University Hospital (CHUV) and Lausanne Medical School, Lausanne, Switzerland
Further Information

Publication History

received 26.2.2007

accepted 20.6.2007

Publication Date:
22 August 2007 (online)

Abstract

Introduction: Cerebrovascular diseases are rarely seen in neurofibromatosis type 1. These include vascular occlusive disease, moyamoya vessels, aneurysms, arteriovenous malformations and fistulae.

Case Report: We describe the case of an infant with genetically proven neurofibromatosis type 1 and progressive brain hemiatrophy over months, due to primary narrowing of intracranial carotid artery branches, as demonstrated by successive brain imaging. She presented with refractory seizures and a progressive hemiparesis associated with developmental delay. Surgical material from hemispherotomy done at 18 months showed severe abnormalities of the small vessels.

Conclusion: Cerebrovascular changes seen in neurofibromatosis can be diffuse and progressive, with secondary hemiparesis, epilepsy and developmental delay.

References

  • 1 Amorosi B, Giustini S, Canci C, Silipo V, Richetta A, Calvieri S. Neurofibromatosis type 1 associated with systemic vasculopathy.  Eur J Dermatol. 1998;  8 271-273
  • 2 Devlin AM, Cross JH, Harkness W, Chong WK, Harding B, Vargha-Khadem F. et al . Clinical outcome of hemispherectomy for epilepsy in childhood and adolescence.  Brain. 2003;  126 556-566
  • 3 Dubois M, Cahn R. Cerebral atrophy diagnosed by electroencephalography in Recklinghausen's neurofibromatosis with mental debility and psychic disorders.  Bull Soc Fr Dermatol Syphiligr. 1951;  58 332-333
  • 4 Hamilton SJ, Friedman JM. Insights into the pathogenesis of neurofibromatosis 1 vasculopathy.  Clin Genet. 2000;  58 341-344
  • 5 Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmiedek P. Moyamoya-like vasculopathy (moyamoya syndrome) in children.  Childs Nerv Syst. 2004;  20 382-391
  • 6 Jansen FE, Worp HB van der, Huffelen A van, Nieuwenhuizen O van. Sturge-Weber syndrome and paroxysmal hemiparesis: epilepsy or ischaemia?.  Dev Med Child Neurol. 2004;  46 783-786
  • 7 Lehrnbecher T, Gassel AM, Rauh V, Kirchner T, Huppertz HI. Neurofibromatosis presenting as a severe systemic vasculopathy.  Eur J Pediatr. 1994;  153 107-109
  • 8 Kuwayama N, Takahashi S, Sonobe M, Kagawa S, Ikeda H. Neurofibromatosis with occlusion of the internal carotid artery: case report.  No Shinkei Geka. 1985;  13 743-747
  • 9 Metry DW, Dowd CF, Barkovich AJ, Frieden IJ. The many faces of PHACE syndrome.  J Pediatr. 2001;  139 117-123
  • 10 Pascual-Castroviejo I. Vascular and nonvascular intracranial malformation associated with external capillary hemangiomas.  Neuroradiology. 1978;  16 82-84
  • 11 Pascual-Castroviejo I, Pascual-Pascual SI, Velazquez-Fragua R, Garcia L, Lopez-Gutierrez JC, Viano-Lopez J. et al . Cutaneous hemangiomas and vascular malformations and associated pathology (Pascual-Castroviejo type II syndrome). Study of 41 patients.  Rev Neurol. 2005;  41 223-236
  • 12 Pistorius MA, Enginger V, Mussini JM, Planchon B. Cerebral atrophy of vascular origin in the course of neurofibromatosis.  J Mal Vasc. 1994;  19 315-319
  • 13 Reubi F. Neurofibromatose et lésions vasculaires.  Schweizerische Medizinische Wochenschrift. 1945;  25 463-465
  • 14 Rosser TL, Vezina G, Packer RJ. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.  Neurology. 2005;  64 553-555
  • 15 Salih MA, Kabiraj M, Al-Jarallah AS, El Desouki M, Othman S, Palkar VA. Hemiconvulsion-hemiplegia-epilepsy syndrome. A clinical, electroencephalographic and neuroradiological study.  Childs Nerv Syst. 1997;  13 257-263
  • 16 Satran L, Letson RD, Seljeskog EL. Neurofibromatosis with congenital glaucoma and buphthalmos in a newborn.  Am J Dis Child. 1980;  134 182-183
  • 17 Sobata E, Ohkuma H, Suzuki S. Cerebrovascular disorders associated with von Recklinghausen's neurofibromatosis: a case report.  Neurosurgery. 1988;  22 544-549
  • 18 Tan N, Urich H. Postictal cerebral hemiatrophy: with a contribution to the problem of crossed cerebellar atrophy.  Acta Neuropathol. 1984;  62 332-339
  • 19 Villemure JG, Mascott CR. Peri-insular hemispherotomy: surgical principles and anatomy.  Neurosurgery. 1995;  37 975-981
  • 20 Vivarelli R, Grosso S, Calabrese F, Farnetani M, Bartolo R Di, Morgese G. et al . Epilepsy in neurofibromatosis 1.  J Child Neurol. 2003;  18 338-342

Correspondence

P. WintermarkMD 

Unit of Pediatric Neurology and Rehabilitation

Medico-Surgical Department of Pediatrics

University Hospital and Lausanne Medical School (CHUV)

1011 Lausanne

Switzerland

Phone: +41/21/314 35 64

Fax: +41/21/314 35 72

Email: Pia.Wintermark@bluemail.ch